Second Malignant Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia
Kjeld Schmiegelow(Rigshospitalet), Maria Grazia Valsecchi(University of Milano-Bicocca), Susana C. Raimondi(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital), Keizo Horibe(Nagoya Medical Center), Franco Locatelli(Bambino Gesù Children's Hospital), Gabriele Escherich(Universität Hamburg), Naomi Winick(Universität Hamburg), Christiane Heydrich(Universität Hamburg), Rob Pieters(Erasmus MC - Sophia Children’s Hospital), Lewis B. Silverman(Boston Children's Hospital), Caroline Piette(Centre hospitalier régional de la Citadelle), Mette Levinsen(Universität Hamburg), Yasushi Ishida(Universität Hamburg), Meenakshi Devidas(National Institutes of Health), Andishe Attarbaschi(St Anna Children's Hospital), Gérard Michel(Hôpital d'Enfants), Der-Cherng Liang(Mackay Memorial Hospital), Brenda Gibson(Royal Hospital for Children), Martin Stanulla(Universität Hamburg), Batia Stark(Schneider Children's Medical Center), André Baruchel(Hôpital Saint-Louis)
Cited by 140
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|914